AstraZeneca PLC (AZN.L)
LSE - LSE Delayed price. Currency in GBp
Add to watchlist
As of 08:59AM BST. Market open.
| Previous close | 10,488.00 |
| Open | 10,458.00 |
| Bid | 10,402.00 x 0 |
| Ask | 10,404.00 x 0 |
| Day's range | 10,386.00 - 10,458.00 |
| 52-week range | 6,499.80 - 11,000.00 |
| Volume | |
| Avg. volume | 2,872,779 |
| Market cap | 161.169B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 129.54 |
| EPS (TTM) | 80.30 |
| Earnings date | 28 Apr 2022 - 02 May 2022 |
| Forward dividend & yield | 2.10 (2.04%) |
| Ex-dividend date | 24 Feb 2022 |
| 1y target est | 110.79 |
- Stockopedia
Are analysts upbeat on the outlook for AstraZeneca?
While the world wrestles with the impact of Covid, inflation and geopolitical strife, investors are naturally wondering what lies in store for some of the coun...
- Business Wire
PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide, Used as an As-Needed Rescue Medicine, Significantly Reduced the Risk of a Severe Exacerbation Compared to Albuterol by 27% in Patients With Asthma
WILMINGTON, Del., May 15, 2022--Full results from the positive MANDALA Phase III trial showed that PT027 (albuterol/budesonide) at two different strengths of budesonide, an inhaled corticosteroid (ICS), used as an as-needed rescue medicine, demonstrated a statistically significant reduction in the risk of a severe exacerbation versus albuterol rescue in patients with moderate to severe asthma.1,2
- Simply Wall St.
AstraZeneca PLC (LON:AZN) Shares Could Be 49% Below Their Intrinsic Value Estimate
Does the May share price for AstraZeneca PLC ( LON:AZN ) reflect what it's really worth? Today, we will estimate the...
© 2022 Yahoo. All rights reserved.
